Baird Maintains Neutral on Inspire Medical Systems, Lowers Price Target to $50

Benzinga Newsdesk www.benzinga.com Negative 67.9%

Neg 67.9% Neu 0% Pos 0%

Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and lowers the price target from $63 to $50.